TY - JOUR
AU - Guerne, Pierre-André
AB - Calcium pyrophosphate dihydrate deposition disease is a common and potentially severe metabolic arthropathy. Early disease (in patients ≤ 60 years old) requires a search for one of the associated metabolic conditions, particularly hemochromatosis. Treatment is primarily symptomatic (no drug is known to prevent the progression of articular destruction). Nonsteroidal anti-inflammatory drugs and intra-articular or systemic glucocorticoids (in small amounts if use is prolonged) are the most useful treatments. Colchicine can be effective to treat recurring pseudogout, and magnesium can be effective on a preventive basis. Methotrexate showed interesting effectiveness in a small, uncontrolled series, and it can be used in the event of failure of the other treatments.
TI - Treating difficult crystal pyrophosphate dihydrate deposition disease
JO - Current Rheumatology Reports
DO - 10.1007/s11926-008-0037-2
DA - 2008-10-24
UR - https://www.deepdyve.com/lp/springer-journals/treating-difficult-crystal-pyrophosphate-dihydrate-deposition-disease-cOygaOFoH0
SP - 228
EP - 234
VL - 10
IS - 3
DP - DeepDyve
ER -